Mediastinal lymph node staging in lung cancer: A prospective comparison of CT/FDG-PET and EUS-FNA/EBUS-TBNA

Mediastinal lymph node staging in lung cancer: A prospective comparison of CT/FDG-PET and EUS-FNA/EBUS-TBNA - Combined approach of EUS-FNA and EBUS-TBNA in mediastinal nodal staging of lung cancer

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000001725

Enrollment

120

Registered

2009-03-01

Start date

2009-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

CT, FDG-PET, EUS-FNA and EBUS-TBNA are performed in patients with lung cancer

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Patients with newly diagnosed or suspected lung cancer based on CT and bronchoscopic findings 2.The clinical stage is judged to be below T4, any N, M0 according to TNM subsets (UICC) 3.Patients obtained written informed consent

Exclusion criteria

Exclusion criteria: 1.Patients with poor medical conditions of grade-4 and -5, according to ASA classification) 2.Patients with bleeding tendency and coagulopathy 3.Case in which the patient refused surgery

Design outcomes

Primary

Measure	Time frame
To compare the accuracy of CT/FDG-PET and EUS-FNA/EBUS-TBNA	—

Secondary

Measure	Time frame
Incidence of EUS-FNA/EBUS-TBNA related complications	—

Countries

Japan

Contacts

Public ContactIchiro Yasuda

Gifu University Hospital First Department of Internal Medicine

YASUDAIC@aol.com058-230-6308

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026